Evidence map›Paper›PMID 42463684›Full record

ArticleScientific reports2026

Broadband achromatic metalens for the short-wave infrared.

Yan He, Adetunmise C Dada

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yan HeSchool of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, UK. y.he.5@research.gla.ac.uk.
Adetunmise C DadaSchool of Physics and Astronomy, University of Glasgow, Glasgow, G12 8QQ, UK. adetunmise.dada@glasgow.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 1.8-2.3 [Formula: see text]m band lies within the short-wavelength infrared (SWIR) region and serves as a key operational window for a wide range of applications, including quantum sensing, molecular spectroscopy, and free-space quantum and classical optical communication. Despite its significance, optical devices operating in this band still face two major challenges: chromatic aberration across the wide spectral range and the difficulty of integration due to bulky optical elements. Metalenses are composed of subwavelength nanostructures that locally control the phase and group delay of light, enabling precise wavefront shaping and broadband dispersion compensation. These capabilities make them highly promising for use in infrared optical systems, particularly in applications such as focusing and imaging for compact integrated devices. In this study, we propose a metalens design based on a CaF[Formula: see text] substrate, where each nanocell consists of a single-bar silicon structure. These nanocells are periodically arranged with a 900 nm period, enabling precise control of dispersion and phase. By systematically fine-tuning the bar length and width, the design enables simultaneous dispersion compensation and phase modulation, achieving stable focusing performance over a broad spectral range. Finite-Difference Time-Domain (FDTD) simulations demonstrate effective suppression of chromatic aberration across 1800-2300 nm, with simulated focal-length variation within 6% of the target value. We further analyze the polarization distribution across the focal spot and find a weak wavelength dependence of the degree of polarization (DoP), which we attribute to the spatially varying polarization state in the high-NA focal region together with the wavelength-dependent anisotropic response of the nanostructures. Meanwhile, this design offers a compact, broadband, and high-performance approach for beam collimation and wavefront shaping in the SWIR band, showing promising potential for applications in quantum communication and sensing systems.

Identifiers

PMID42463684
PMCPMC13376357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.